Back to Journals » Biologics: Targets and Therapy

ESCI
SJR OA
CiteScore
Impact Factor

Biologics: Targets and Therapy

ISSN: 1177-5491


       

Editor-in-Chief: Professor Shein-Chung Chow

ISSN: 1177-5475 (Print) - went to online only in 2009

An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.


This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

 

 

 

  

 

 

Articles:

Latest articles:

- 5 records -

Case report

Successful Fistula Closure After Treatment with Colostomy and Infliximab in a Patient with Ulcerative Colitis Complicated by Rectovaginal Fistula

Katsube S, Matsumoto S, Misawa M, Kakizawa N, Hashimoto R, Mizutani T, Matsumoto K, Yoshikawa S, Mashima H

Biologics: Targets and Therapy 2024, 18:107-113

Published Date: 6 May 2024

Original Research

TNFSF13B rs9514828 C>T Polymorphism is Associated with Incidence of Atherosclerosis and Therapeutic Outcomes in Patients with Systemic Lupus Erythematosus

Fajar DR, Rostinawati T, Hamijoyo L, Sahiratmadja E, Amalia R, Barliana MI

Biologics: Targets and Therapy 2024, 18:95-106

Published Date: 3 May 2024

Review

Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy

Soberanis Pina P, Lheureux S

Biologics: Targets and Therapy 2024, 18:79-93

Published Date: 21 March 2024

Review

MDMX in Cancer: A Partner of p53 and a p53-Independent Effector

Lin W, Yan Y, Huang Q, Zheng D

Biologics: Targets and Therapy 2024, 18:61-78

Published Date: 31 January 2024

Review

Advances with Platelet-Rich Plasma for Bone Healing

Bacevich BM, Smith RDJ, Reihl AM, Mazzocca AD, Hutchinson ID

Biologics: Targets and Therapy 2024, 18:29-59

Published Date: 25 January 2024


Read more articles